IDEAL LIFE and Bayada Nurses Reduce Hospitalizations by 40-60 Percent for Patients with Congestive Heart Failure (CHF) and Hypertension

* Reuters is not responsible for the content in this press release.

Mon Jun 1, 2009 8:00am EDT

Wireless Telehealth Products Contribute to Major Cost-Savings and Optimal
Patient Care
TORONTO--(Business Wire)--
IDEAL LIFE, INC. and home care agency Bayada Nurses Inc. announced today that
hospitalizations for patients using IDEAL LIFE`s remote health management
products for CHF and hypertension have decreased 40 to 60 percent since the
program began in September 2007. The clinical results were so favorable that
Bayada Nurses, one of the nation`s largest home health providers, has expanded
use of the IDEAL LIFE system across offices in Pennsylvania, Arizona and New
Jersey. 

Participating patients monitored their daily weight fluctuations - a key
indicator of heart failure - and blood pressure using both a Bluetooth-enabled
digital weight scale (the IDEAL LIFE Body Manager) and a blood pressure monitor
(the IDEAL LIFE BP-Manager). The wireless telemedicine devices easily and
automatically store and send health information to designated medical
professionals, enabling them to make timely decisions that can prevent
unnecessary hospital stays. Bayada staff also found that IDEAL LIFE`s products
provided opportunities for "teachable moments" with their patients, especially
when symptoms were most acute. 

"Preventing just one hospitalization can save health plans as much as $30,000,"
said Brian Farber, director of the Telehealth Program at Bayada Nurses. "Using
IDEAL LIFE`s affordable and effective products, we now have the potential to
help millions of people better manage their health and reduce healthcare costs."


IDEAL LIFE is one of the most widely-used systems for remote health monitoring
in North America, with FDA-approved products designed for individuals with
chronic conditions such as CHF, diabetes, obesity, and hypertension. The
company`s consumer-inspired monitoring devices can be used with cell phones,
land line phones, and the Internet, and have gained enthusiastic support from
medical experts across the country. 

"More than two-thirds of the population over 65 will eventually need some form
of long-term care," said Jason Goldberg, president and founder of IDEAL LIFE.
"As assisted living costs continue to rise, we are more committed than ever to
developing new healthcare solutions that truly benefit the quality of people`s
lives." 

For more information, please visit www.ideallifeonline.com or contact Jason
Goldberg, president of IDEAL LIFE, at 416-489-1494,
jgoldberg@ideallifeonline.com. 

About IDEAL LIFE, INC.

Based in Toronto, Canada, IDEAL LIFE is a multinational company that delivers
timely and accurate health information through collaborative solutions that are
secure, reliable, and mobile. The FDA-approved products are wireless,
easy-to-use and available for a fraction of the cost of competing products,
requiring no extra cables, a computer, or extra steps. With an open technology
platform that supports customization and seamlessly integrates with existing
information based systems, IDEAL LIFE eliminates the need for new software or
data reconfiguration. Products are designed for individuals with chronic
conditions such as congestive heart failure, hypertension, diabetes, asthma, and
obesity. For more information, visit www.ideallifeonline.com. 

About Bayada Nurses

Founded in 1975, Bayada Nurses is an independently-owned home health agency that
employs more than 12,000 nurses, home health aides, therapists and social
workers in more than 140 offices and 18 states, as well as the UK. Bayada Nurses
provides skilled, rehabilitative, therapeutic, personal care, and support
services to people of all ages in the comfort of their own homes. For more
information, visit www.bayada.com. 



Scott Public Relations
Joy Scott, 818-610-0270
joy@scottpublicrelations.com

Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.